Light. Truth. Clarity.
Novo Nordisk has launched Wegovy, the first oral version of its popular obesity drug, which is now available at pharmacies across the U. S. The pill, approved by the FDA in December 2022, offers a more affordable option compared to the previously available injectable form and is expected to trigger a price competition among similar weight-loss drugs.
Credit: A pill form of Wegovy, the popular obesity drug previously available only by injection, is now being stocked by pharmacies.Novo Nordiskhide captiontoggle captionNovo Nordisk
This quick summary is automatically generated using AI based on reports from multiple news sources. The content has not been reviewed or verified by humans. For complete details, accuracy, and context, please refer to the original published articles.
